TREACE MEDICAL CONCEPTS, INC.

For the period ended Jun 30, 2026. Filed Aug 7, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 7, 2026

TMCI$4.88+2.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Statements of Operations and Comprehensive Loss

(in thousands, except share and per share amounts)

	Three Months Ended June 30,		Six Months Ended June 30,
	2026	2025	2026	2025
Revenue	$45,376	$47,387	$92,574	$99,957
Cost of goods sold	9,769	9,635	19,560	20,312
Gross profit	35,607	37,752	73,014	79,645
Operating expenses
Sales and marketing	30,940	33,084	64,715	69,206
Research and development	4,376	5,498	8,998	11,060
General and administrative	15,249	16,144	31,426	31,935
Total operating expenses	50,565	54,726	105,139	112,201
Loss from operations	(14,958)	(16,974)	(32,125)	(32,556)
Interest income	445	775	946	1,616
Interest expense	(1,562)	(1,321)	(3,132)	(2,632)
Other income, net	202	122	477	252
Other non-operating income (expense), net	(915)	(424)	(1,709)	(764)
Net loss	$(15,873)	$(17,398)	$(33,834)	$(33,320)
Other comprehensive income (loss)
Unrealized gain (loss) on marketable securities	(26)	(7)	(124)	(47)
Comprehensive loss	$(15,899)	$(17,405)	$(33,958)	$(33,367)
Net loss per share, basic and diluted	$(0.24)	$(0.28)	$(0.52)	$(0.53)
Weighted-average shares used in computing net loss per share, basic and diluted	65,049,844	63,006,891	64,822,526	62,843,337

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.